| High (N=5) |
Low (N=92) |
P-value | |
|---|---|---|---|
| Age | |||
| Mean (SD) | 52.8 (14.2) | 55.3 (10.1) | 0.23 |
| Median [Min, Max] | 50.0 [36.0, 73.0] | 55.0 [24.0, 82.0] | |
| Operation_history | |||
| Direct_surgery | 4 (80.0%) | 61 (66.3%) | 0.809 |
| Septal_tumor_reduction | 0 (0%) | 1 (1.1%) | |
| Surgery_after_neoadjuvant | 1 (20.0%) | 30 (32.6%) | |
| Type | |||
| CCC | 1 (20.0%) | 1 (1.1%) | 0.00832 |
| EC | 1 (20.0%) | 2 (2.2%) | |
| HGSC | 3 (60.0%) | 84 (91.3%) | |
| LGSC | 0 (0%) | 2 (2.2%) | |
| MC | 0 (0%) | 2 (2.2%) | |
| Missing | 0 (0%) | 1 (1.1%) | |
| Clinical_stage | |||
| I | 0 (0%) | 1 (1.1%) | 0.8 |
| II | 1 (20.0%) | 7 (7.6%) | |
| III | 2 (40.0%) | 42 (45.7%) | |
| IV | 2 (40.0%) | 42 (45.7%) | |
| Planting_metastasis | |||
| No | 0 (0%) | 7 (7.6%) | 1 |
| Yes | 5 (100%) | 85 (92.4%) | |
| Lymph.node_metastasis | |||
| No | 2 (40.0%) | 39 (42.4%) | 1 |
| Yes | 3 (60.0%) | 53 (57.6%) |